COVID-19 vaccine launched in Europe

The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens.

COVID-19 vaccine launched in Europe
Colin Kerr
Colin Kerr
Published: Sunday, December 27, 2020
The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens. The vaccine was intended to be officially rolled out on Sunday December 27 but on Saturday December 26 Germany, Hungary and Slovakia began giving out their first coronavirus vaccine shots in advance of the European Union’s campaign for a coordinated rollout Sunday across the union's 27 nations. European Commission President Ursula von der Leyen said on Saturday that the Pfizer-BioNTech vaccine had been delivered to all 27 member states. "Today, we start turning the page on a difficult year. The #COVID19 vaccine has been delivered to all EU countries. Vaccination will begin tomorrow across the EU," Ms von der Leyen said in a tweet. "The #EUvaccinationdays are a touching moment of unity. Vaccination is the lasting way out of the pandemic," said Ms von der Leyen. The European Centre for Disease Prevention and Control (ECDC) has stated that in the initial phases of the vaccine deployment, it is expected that demand will exceed supply. "It will be important to manage expectations through appropriate communication regarding the choices of vaccine strategies. It will also be important to consider groups or settings that may have a disproportionate risk of exposure," said an ECDC spokesperson. "Given the many unknowns in relation to COVID-19 vaccines’ characteristics, deployment, supply, and uptake, non-pharmaceutical interventions should continue to be applied, as recommended by public health authorities, following the introduction of COVID-19 vaccination. Vaccination strategies will need to be adaptable over time to unfolding events taking into account the emerging evidence. ECDC will continue to monitor factors like COVID-19 vaccine effectiveness, confidence, uptake, supply, deployment, and future emerging variants that could have an impact on the response to COVID-19 vaccines," said the spokesperson. https://www.ecdc.europa.eu/en/news-events/ecdc-releases-vaccination-rollout-strategies-eueea
Latest Articles
Nutrition and the Eye: A Recipe for Success

A look at the evidence for tasty ways of lowering risks and improving ocular health.

Read more...

New Award to Encourage Research into Sustainable Practices

Read more...

Sharing a Vision for the Future

ESCRS leaders update Trieste conference on ESCRS initiatives.

Read more...

Extending Depth of Satisfaction

The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.

Read more...

Conventional Versus Laser-Assisted Cataract Surgery

Evidence favours conventional technique in most cases.

Read more...

AI Scribing and Telephone Management

Automating note-taking and call centres could boost practice efficiency.

Read more...

AI Analysis and the Cornea

A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.

Read more...

Cooking a Feast for the Eyes

A cookbook to promote ocular health through thoughtful and traditional cuisine.

Read more...

Need to Know: Spherical Aberration

Part three of this series examines spherical aberration and its influence on higher-order aberrations.

Read more...

Generating AI’s Potential

How generative AI impacts medicine, society, and the environment.

Read more...